Sinocelltech Group (688520.SS) Stock Price

Sinocelltech Group Price

SSE·CLOSED
39.29CNY+0.48 (+1.23 %)
Market closed

Over the last 7 years Sinocelltech Group grew revenue by 137.0% annually, reaching 2.51 B CNY. For Sinocelltech Group, the net margin of 4.3% is up versus -215,909.1% a few years ago. The consensus 12-month price target for Sinocelltech Group is 56.10 CNY, about 42.8% above where the stock trades today. Of 6 analysts, 5 rate the stock a buy — an overall Buy consensus. The stock trades about 23% above its 52-week low.

Sinocelltech Group stock price

Volume
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Sinocelltech Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Sinocelltech Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Sinocelltech Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Sinocelltech Group Stock Price History
DateSinocelltech Group Price
8/12/202639.29 CNY
8/11/202638.81 CNY
8/10/202637.86 CNY
8/7/202637.82 CNY
8/6/202635.02 CNY
8/5/202636.32 CNY
8/4/202635.10 CNY
8/3/202633.83 CNY
7/31/202633.75 CNY
7/30/202633.15 CNY
7/29/202634.30 CNY
7/28/202633.93 CNY
7/27/202634.73 CNY
7/24/202633.76 CNY
7/23/202635.84 CNY
7/22/202636.60 CNY
7/21/202636.05 CNY
7/20/202636.91 CNY
7/17/202636.41 CNY
7/16/202638.80 CNY
7/15/202638.20 CNY
7/14/202636.26 CNY
7/13/202636.54 CNY
7/10/202637.37 CNY
7/9/202636.27 CNY
7/8/202636.26 CNY
7/7/202637.40 CNY
7/6/202639.80 CNY
7/3/202637.66 CNY
7/2/202637.00 CNY
7/1/202637.60 CNY
6/30/202634.21 CNY
6/29/202635.30 CNY
6/26/202633.00 CNY
6/25/202634.99 CNY
6/24/202634.70 CNY
6/23/202634.20 CNY
6/22/202632.07 CNY
6/18/202634.52 CNY
6/17/202633.02 CNY
6/16/202633.41 CNY
6/15/202634.31 CNY
6/12/202634.03 CNY
6/11/202632.99 CNY
6/10/202634.03 CNY
6/9/202634.32 CNY
6/8/202634.27 CNY
6/5/202635.34 CNY
6/4/202635.31 CNY
6/3/202635.90 CNY
6/2/202637.08 CNY
6/1/202638.90 CNY
5/29/202638.04 CNY
5/28/202638.44 CNY
5/27/202639.00 CNY
5/26/202639.09 CNY
5/25/202639.67 CNY
5/22/202640.55 CNY
5/21/202642.11 CNY
5/20/202641.53 CNY
5/19/202641.84 CNY
5/18/202641.24 CNY
5/15/202642.10 CNY
5/14/202642.01 CNY
5/13/202642.77 CNY
5/12/202643.35 CNY
5/11/202644.21 CNY
5/8/202642.29 CNY
5/7/202642.87 CNY
5/6/202641.66 CNY
4/30/202641.18 CNY
4/29/202641.34 CNY
4/28/202641.11 CNY
4/27/202641.48 CNY
4/24/202640.85 CNY
4/23/202641.52 CNY
4/22/202642.87 CNY
4/21/202643.48 CNY
4/20/202642.74 CNY
4/17/202644.25 CNY
4/16/202645.01 CNY
4/15/202643.28 CNY
4/14/202641.88 CNY
4/13/202641.57 CNY
4/10/202641.90 CNY
4/9/202641.08 CNY
4/8/202642.54 CNY
4/7/202642.58 CNY
4/3/202641.67 CNY
4/2/202643.39 CNY
4/1/202643.14 CNY
3/31/202640.32 CNY
3/30/202641.12 CNY
3/27/202641.46 CNY
3/26/202637.96 CNY
3/25/202638.45 CNY
3/24/202638.33 CNY
3/23/202636.40 CNY
3/20/202638.00 CNY
3/19/202639.35 CNY
3/18/202640.43 CNY
3/17/202640.30 CNY
3/16/202640.70 CNY
3/13/202639.40 CNY
3/12/202639.21 CNY
3/11/202639.55 CNY
3/10/202640.18 CNY
3/9/202639.36 CNY
3/6/202639.89 CNY
3/5/202637.09 CNY
3/4/202636.89 CNY
3/3/202637.00 CNY
3/2/202638.18 CNY
2/27/202639.41 CNY
2/26/202639.10 CNY
2/25/202639.95 CNY
2/24/202639.50 CNY
2/13/202639.38 CNY
2/12/202640.01 CNY
2/11/202640.43 CNY
2/10/202640.59 CNY
2/9/202640.25 CNY
2/6/202640.00 CNY
2/5/202639.73 CNY
2/4/202639.90 CNY
2/3/202639.78 CNY
2/2/202638.90 CNY
1/30/202641.85 CNY
1/29/202643.25 CNY
1/28/202644.08 CNY
1/27/202644.90 CNY
1/26/202645.88 CNY
1/23/202646.33 CNY
1/22/202645.29 CNY
1/21/202645.47 CNY
1/20/202645.46 CNY
1/19/202646.46 CNY
1/16/202647.09 CNY
1/15/202647.24 CNY
1/14/202648.45 CNY
1/13/202649.00 CNY
1/12/202648.36 CNY
1/9/202649.16 CNY
1/8/202647.73 CNY
1/7/202647.78 CNY
1/6/202646.51 CNY
1/5/202646.90 CNY
12/31/202543.31 CNY
12/30/202543.59 CNY
12/29/202543.95 CNY
12/26/202544.22 CNY
12/25/202544.55 CNY
12/24/202543.80 CNY
12/23/202543.70 CNY
12/22/202544.26 CNY
12/19/202544.57 CNY
12/18/202544.32 CNY
12/17/202544.50 CNY
12/16/202543.82 CNY
12/15/202544.65 CNY
12/12/202546.55 CNY
12/11/202547.03 CNY
12/10/202547.10 CNY
12/9/202546.69 CNY
12/8/202546.66 CNY
12/5/202546.15 CNY
12/4/202546.00 CNY
12/3/202546.33 CNY
12/2/202546.80 CNY
12/1/202547.32 CNY
11/28/202548.31 CNY
11/27/202547.52 CNY
11/26/202547.85 CNY
11/25/202547.50 CNY
11/24/202547.18 CNY
11/21/202546.17 CNY
11/20/202547.58 CNY
11/19/202548.27 CNY
11/18/202549.38 CNY
11/17/202549.86 CNY
11/14/202551.45 CNY
11/13/202551.73 CNY
11/12/202550.16 CNY
11/11/202550.95 CNY
11/10/202550.65 CNY
11/7/202549.91 CNY
11/6/202550.53 CNY
11/5/202551.27 CNY
11/4/202551.25 CNY
11/3/202554.26 CNY
10/31/202553.70 CNY
10/30/202552.96 CNY
10/29/202552.63 CNY
10/28/202552.85 CNY
10/27/202552.37 CNY
10/24/202551.99 CNY
10/23/202551.83 CNY
10/22/202552.73 CNY
10/21/202553.00 CNY
10/20/202552.56 CNY
10/17/202552.89 CNY
10/16/202554.59 CNY
10/15/202555.03 CNY
10/14/202552.46 CNY
10/13/202553.90 CNY
10/10/202554.59 CNY
10/9/202556.38 CNY
9/30/202555.80 CNY
9/29/202555.41 CNY
9/26/202554.65 CNY
9/25/202556.41 CNY
9/24/202556.84 CNY
9/23/202555.91 CNY
9/22/202557.95 CNY
9/19/202557.80 CNY
9/18/202558.58 CNY
9/17/202559.97 CNY
9/16/202559.32 CNY
9/15/202559.80 CNY
9/12/202560.00 CNY
9/11/202560.12 CNY
9/10/202559.14 CNY
9/9/202560.88 CNY
9/8/202562.25 CNY
9/5/202563.00 CNY
9/4/202561.37 CNY
9/3/202563.48 CNY
9/2/202564.32 CNY
9/1/202565.87 CNY
8/29/202563.50 CNY
8/28/202564.28 CNY
8/27/202565.49 CNY
8/26/202566.65 CNY
8/25/202568.51 CNY
8/22/202568.06 CNY
8/21/202568.35 CNY
8/20/202569.31 CNY
8/19/202571.40 CNY
8/18/202573.00 CNY
8/15/202573.20 CNY
Access this data via the Eulerpool API
Get Free API Key

Sinocelltech Group Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
134.39 M CNY
-837.80 M CNY
-866.85 M CNY
Jan 1, 2022
1.02 B CNY
-275.90 M CNY
-519.00 M CNY
Jan 1, 2023
1.89 B CNY
112.00 M CNY
-396.02 M CNY
Jan 1, 2024
2.51 B CNY
666.95 M CNY
108.47 M CNY
Jan 1, 2025 (e)
2.19 B CNY
-809.94 M CNY
-31.17 M CNY
Jan 1, 2026 (e)
1.65 B CNY
-607.50 M CNY
-405.26 M CNY
Jan 1, 2027 (e)
1.98 B CNY
-731.47 M CNY
-204.85 M CNY
Jan 1, 2028 (e)
2.27 B CNY
-836.26 M CNY
13.36 M CNY

Sinocelltech Group Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 12:03 PM
 
REVENUEB CNY
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB CNY
EBITM CNY
EBIT MARGIN%
NET INCOMEM CNY
NET INCOME GROWTH%
SHARESM
201720182019202020212022202320242025e2026e2027e2028e
0.01–––0.131.021.892.512.191.651.982.27
–-60.00–––663.4384.4633.12-12.70-24.9920.4314.34
60.00100.00120,050.00–94.7896.6894.8695.5895.5895.5895.5895.58
––2.402.400.130.991.792.402.101.571.892.16
-143.00-455.00-793.00-709.00-837.00-275.00112.00666.00-809.00-607.00-731.00-836.00
-2,860.00-22,750.00-39,650.00–-624.63-26.885.9426.51-36.89-36.90-36.90-36.91
-141.00-453.00-794.00-712.00-866.00-518.00-396.00108.00-31.00-405.00-204.0013.00
–221.2875.28-10.3321.63-40.18-23.55-127.27-128.701,206.45-49.63-106.37
42.7543.20380.25409.49435.34436.13445.34445.34445.34445.34445.34445.34
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Sinocelltech Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Sinocelltech Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Sinocelltech Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Sinocelltech Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Sinocelltech Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Sinocelltech Group stock margins

The Sinocelltech Group margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Sinocelltech Group. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Sinocelltech Group.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2020
81.82 %
-214,996.95 %
-215,909.08 %
Jan 1, 2021
94.76 %
-623.39 %
-645.01 %
Jan 1, 2022
96.69 %
-26.96 %
-50.72 %
Jan 1, 2023
94.87 %
5.93 %
-20.98 %
Jan 1, 2024
95.58 %
26.54 %
4.32 %
Jan 1, 2025 (e)
95.58 %
-36.92 %
-1.42 %
Jan 1, 2026 (e)
95.58 %
-36.92 %
-24.63 %
Jan 1, 2027 (e)
95.58 %
-36.92 %
-10.34 %

Sinocelltech Group Stock Revenue, EBIT, Earnings per Share

The Sinocelltech Group earnings per share therefore indicates how much revenue Sinocelltech Group has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2020
0.00 CNY
-1.73 CNY
-1.74 CNY
Jan 1, 2021
0.31 CNY
-1.92 CNY
-1.99 CNY
Jan 1, 2022
2.35 CNY
-0.63 CNY
-1.19 CNY
Jan 1, 2023
4.24 CNY
0.25 CNY
-0.89 CNY
Jan 1, 2024
5.64 CNY
1.50 CNY
0.24 CNY
Jan 1, 2025 (e)
4.93 CNY
-1.82 CNY
-0.07 CNY
Jan 1, 2026 (e)
3.70 CNY
-1.36 CNY
-0.91 CNY
Jan 1, 2027 (e)
4.45 CNY
-1.64 CNY
-0.46 CNY

Sinocelltech Group business model & stock analysis

Sinocelltech Group Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Sinocelltech Group historical P/E ratio, EBIT multiple, and P/S ratio

Sinocelltech Group annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Sinocelltech Group shares outstanding

The number of shares of Sinocelltech Group was 445.34 M in 2025. This indicates how many shares Sinocelltech Group is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2020
409.49 M Stocks
Jan 1, 2021
435.34 M Stocks
Jan 1, 2022
436.13 M Stocks
Jan 1, 2023
445.34 M Stocks
Jan 1, 2024
445.34 M Stocks
Jan 1, 2025 (e)
445.34 M Stocks
Jan 1, 2026 (e)
445.34 M Stocks
Jan 1, 2027 (e)
445.34 M Stocks

Current Sinocelltech Group forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
83.33 % (5)
Hold
16.67 % (1)
Sell
0.00 % (0)
12M Price Target
56.10
Last Price
39.29
Currency
CNY
12M Return Potential
42.78 %
LTM Return
0 %

EESG©

Eulerpool ESG Scorecard© for the Sinocelltech Group stock

42/100
50
Environment
56
Social
19
Governance
E

Environment

20
Scope 1 - Direct Emissions—
Scope 2 - Indirect emissions from purchased energy—
Scope 3 - Indirect emissions within the value chain—
Total CO₂ emissions—
CO₂ reduction strategy
Coal energy
Nuclear power
Animal experiments
Fur & Leather—
Pesticides—
Palm Oil—
Tobacco
Genetically modified organisms
Climate concept—
Sustainable forestry—
Recycling regulations
Environmentally friendly packaging
Hazardous substances
Fuel consumption and efficiency
Water consumption and efficiency
S

Social

20
Percentage of female employees—
Percentage of women in management—
Percentage of Asian employees—
Share of Asian management—
Percentage of Hispanic/Latino employees—
Hispano/Latino Management share—
Percentage of Black employees—
Black Management Share—
Percentage of white employees—
White Management Share—
Adult content
Alcohol
Weapons—
Firearms
Gambling
Military contracts
Human rights concept
Privacy concept—
Occupational health and safety
Catholic
G

Governance (Corporate Governance)

4
Environmental reporting
Stakeholder Engagement
Call Back Policies
Antitrust law

The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.

Sinocelltech Group shareholder structure

% Name
4.57965%
Nanchang Shenzhou Anyuan Enterprise Management Consulting Partnership LP
Nanchang Shenzhou Anyuan Enterprise Management Consulting Partnership LP
1.60715%
Nanchang Shenzhou Anheng Enterprise Management Consulting Partnership LP
Nanchang Shenzhou Anheng Enterprise Management Consulting Partnership LP
0.40475%
Anyi Shenzhou Ancheng Enterprise Management Consulting Partnership (LP)
Anyi Shenzhou Ancheng Enterprise Management Consulting Partnership (LP)
0.40413%
Anyi Shenzhou Anqian Enterprise Management Consulting Partnership (LP)
Anyi Shenzhou Anqian Enterprise Management Consulting Partnership (LP)
0.39450%
Anyi Shenzhou Anlong Enterprise Management Consulting Partnership (LP)
Anyi Shenzhou Anlong Enterprise Management Consulting Partnership (LP)
0.38869%
Anyi Shenzhou Anhong Enterprise Management Consulting Partnership (LP)
Anyi Shenzhou Anhong Enterprise Management Consulting Partnership (LP)

Sinocelltech Group Beneficial Ownership Filings (SEC 13D/G)

Free Float
10.3%
Float Shares
-
Shares Outstanding
-

Sinocelltech Group Executives and Management Board

15 members · avg. age 57 · 40 % women

WG

Ms. Wenlin Gai (59)

Distinguished Clinical Research Expert

2.57 M CNY

Management

ZL

Mr. Zhanghua Lan (61)

Deputy General Manager · since 2019

2.11 M CNY
CL

Ms. Chunxia Luo (53)

Leader of Pilot Workshop and Production Workshop

1.47 M CNY
JM

Ms. Jie Ma (52)

Chief Financial Officer, Director · since 2023

944,700.00 CNY
FP

Mr. Fanbin Pan (46)

Head of Engineering Equipment Department

831,000.00 CNY

Board of Directors

YW

Mr. Yang Wang (65)

Deputy General Manager, Director · since 2010

3.38 M CNY
LT

Mr. Liming Tang (44)

Deputy General Manager, Secretary of the Board, Director · since 2016

2.40 M CNY
CS

Ms. Chunyun Sun (48)

Executive Director of Preclinical R&D Center

1.38 M CNY
YZ

Ms. Yanjing Zhang (49)

Executive Director of Preclinical R&D Center

1.26 M CNY
GZ

Ms. Guifen Zhao (57)

Director · since 2017

456,600.00 CNY
WH

Mr. Wei He (50)

Independent Director

180,000.00 CNY

Sinocelltech Group Supply Chain

Sinocelltech Group Supply Chain

Correlation: how closely stock prices move together

Same directionNo relationOpposite
1 companies
#NameTrend
1
Sino Biological A
Supplier·Biotechnology·CN
0.28
0.64
0.72
0.83
—
—

Frequently asked questions about Sinocelltech Group

Analysts currently set an average price target of 56.10 CNY for the Sinocelltech Group stock (median: 56.10 CNY), implying +42.8 % versus the latest price. The consensus is based on 6 analyst ratings.

Sinocelltech Group Analyst Price Targets 2026

6 analysts currently rate the Sinocelltech Group stock: 5 recommend buying, 1 holding and 0 selling. For 2026, analysts expect Sinocelltech Group to generate revenue of 1.65 B CNY and earnings per share of -0.91 CNY.

Sinocelltech Group Analyst Price Targets 2026

Converted at the current exchange rate, the Sinocelltech Group share trades at 5.05 EUR (39.29 CNY).

No history available for Sinocelltech Group.

The expected revenue of Sinocelltech Group is 1.65 B CNY. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Sinocelltech Group is -405.26 M CNY. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Sinocelltech Group is currently -43.18. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sinocelltech Group stock.

The price-to-sales ratio (P/S) of Sinocelltech Group is currently 10.63. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sinocelltech Group stock.

The Eulerpool Quality Score for Sinocelltech Group is 5/10.

The ISIN of Sinocelltech Group is CNE100003ZL3. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Sinocelltech Group is 688520.SS. The ticker symbol is used to trade Sinocelltech Group shares on the stock exchange.

Sinocelltech Group paid dividends every year for the past 0 years.

Sinocelltech Group is assigned to the 'Health' sector.

The dividends of Sinocelltech Group are distributed in CNY.

All fundamentals and in-depth analysis of Sinocelltech Group

Our stock analysis for Sinocelltech Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sinocelltech Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Sinocelltech Group Stock
Sinocelltech Group Revenue→
Sinocelltech Group Stock
Sinocelltech Group Net Income→
Sinocelltech Group Stock
Sinocelltech Group P/E→
Sinocelltech Group Stock
Sinocelltech Group P/S→
Sinocelltech Group Stock
Sinocelltech Group EBIT→
Sinocelltech Group Stock
Sinocelltech Group Dividend→
Sinocelltech Group Stock
Sinocelltech Group Directors Dealings→
Sinocelltech Group Stock
Sinocelltech Group Stocks→
Sinocelltech Group Stock
Sinocelltech Group Market capitalization→
Sinocelltech Group Stock
Sinocelltech Group Debt→
Sinocelltech Group Stock
Sinocelltech Group Liabilities→
Sinocelltech Group Stock
Sinocelltech Group Equity→
Sinocelltech Group Stock
Sinocelltech Group AAQS→
Sinocelltech Group Stock
Sinocelltech Group Employees→
Sinocelltech Group Stock
Sinocelltech Group ROE→
Sinocelltech Group Stock
Sinocelltech Group ROA→
Sinocelltech Group Stock
Sinocelltech Group ROCE→
Sinocelltech Group Stock
Sinocelltech Group News→
Sinocelltech Group Stock
Sinocelltech Group Analyst Price Targets→

Health Stocks

Sinohealth HoldingsSinocareSinoMab BioScienceSino Medical Sciences TechnologySinopharm Group CoSino BiopharmaceuticalSinotherapeuticsSino BiologicalSinphar Pharmaceutical CoSinil Pharmaceutical CoSinsin Pharmaceutical CoSingular Health GroupAll Stocks A–Z →